Skip to main content

FDA Urges Public to Use Heimlich Not 'Anti-Choking' Devices to Save Lives

Medically reviewed by Carmen Pope, BPharm. Last updated on April 24, 2024.

By Physician’s Briefing Staff HealthDay Reporter

TUESDAY, April 23, 2024 -- The U.S. Food and Drug Administration is advising people to use the Heimlich maneuver to aid a choking victim and not rely on over-the-counter anti-choking devices.

"The safety and effectiveness of over-the-counter anti-choking devices have not been established; they are not FDA approved or cleared," the agency said in a safety communication issued Monday.

The FDA admitted that it is "not aware of any serious injuries reported with the use of these devices, and no deaths have been associated with the use of anti-choking devices." However, the agency is concerned that fumbling with these one-use-only devices could cost precious time in an emergency.

The leading device, the $70 LifeVac, comes with a mask that fits over a person's nose or mouth and attaches to a plunger-like bellows. Pushing the bellows down and then quickly up creates a vacuum to clear the airway.

The LifeVac website contains a "Hall of Saves" presenting thousands of cases in which the device has saved a child or adult from choking, as well as a page devoted to medical journal articles about the gadget.

The company informs consumers that the LifeVac is "FDA registered as a Class II medical device," adding that "it is exempt from premarket clearance. The FDA does not require a premarket review of the LifeVac device. Currently, in the United States, all portable suction devices are required to be registered with the FDA, not approved."

Still, the FDA says people should not rely on these devices because established choking rescue protocols, which rely on the Heimlich, "have a high rate of success and can be carried out immediately without devices, saving valuable time."

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States

THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...

Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening

WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...

American College of Surgeons, Oct. 19-22

The annual meeting of the American College of Surgeons was held this year from Oct. 19 to 22 in San Francisco and attracted participants from around the world, including...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.